BIOMAT Database Logo BIOMAT Database Logo

[Interactions of low density lipoproteins with glycosaminoglycans and foam cells within the atherosclerotic aorta (author's transl)]. 1979

A W Popow, and A S Kusnezow, and A G Winogradow

Very low and low density lipoproteins (VLDL and LDL) isolated from aorta's intima in salt solution were predominantly, associated in complex with glycosaminoglycans (GAG): hyaluronic acid, chondroitinsulfate A(C), heparin. Heparin was detected mainly in complex, isolated from fibrosis plaque. Studying of interaction between LDL and foam cells showed that cells in situ as far as under their incubation in medium with llow LDL concentration primarily accumulated lipid of lipoprotein particles. Incubation foam cells under increased concentration of lipoprotein in medium led to greater entry of radioactivity into the cells. However, there was less tendency for primarily lipid accumulation. Increase of LDL concentration correlated with larger cell's CO2 production. GAG prevented this effect of LDL. Besides LDL uptake was decreased in this condition too. It is possible that GAG effect lipoprotein properties and in such a way the character of their interaction with cells.

UI MeSH Term Description Entries
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008079 Lipoproteins, VLDL A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues. Pre-beta-Lipoprotein,Prebeta-Lipoprotein,Prebeta-Lipoproteins,Very Low Density Lipoprotein,Very-Low-Density Lipoprotein,Very-Low-Density Lipoproteins,Lipoprotein VLDL II,Lipoproteins, VLDL I,Lipoproteins, VLDL III,Lipoproteins, VLDL1,Lipoproteins, VLDL2,Lipoproteins, VLDL3,Pre-beta-Lipoproteins,Lipoprotein, Very-Low-Density,Lipoproteins, Very-Low-Density,Pre beta Lipoprotein,Pre beta Lipoproteins,Prebeta Lipoprotein,Prebeta Lipoproteins,VLDL Lipoproteins,VLDL1 Lipoproteins,VLDL2 Lipoproteins,VLDL3 Lipoproteins,Very Low Density Lipoproteins
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005487 Foam Cells Lipid-laden macrophages originating from monocytes or from smooth muscle cells. Cell, Foam,Cells, Foam,Foam Cell
D005609 Free Radicals Highly reactive molecules with an unsatisfied electron valence pair. Free radicals are produced in both normal and pathological processes. Free radicals include reactive oxygen and nitrogen species (RONS). They are proven or suspected agents of tissue damage in a wide variety of circumstances including radiation, damage from environment chemicals, and aging. Natural and pharmacological prevention of free radical damage is being actively investigated. Free Radical
D006025 Glycosaminoglycans Heteropolysaccharides which contain an N-acetylated hexosamine in a characteristic repeating disaccharide unit. The repeating structure of each disaccharide involves alternate 1,4- and 1,3-linkages consisting of either N-acetylglucosamine (see ACETYLGLUCOSAMINE) or N-acetylgalactosamine (see ACETYLGALACTOSAMINE). Glycosaminoglycan,Mucopolysaccharides

Related Publications

A W Popow, and A S Kusnezow, and A G Winogradow
Foam cells in explants of atherosclerotic rabbit aortas have receptors for beta-very low density lipoproteins and modified low density lipoproteins.
January 1983, Arteriosclerosis (Dallas, Tex.),
A W Popow, and A S Kusnezow, and A G Winogradow
[Interactions of low density lipoproteins with elastin in the intima and media from the intact and atherosclerotic human aorta].
February 2000, Biulleten' eksperimental'noi biologii i meditsiny,
A W Popow, and A S Kusnezow, and A G Winogradow
Interactions of high density lipoproteins with very low and low density lipoproteins during lipolysis.
March 1988, Journal of lipid research,
A W Popow, and A S Kusnezow, and A G Winogradow
[Lipoproteins of the vascular wall: complex formation with glycosaminoglycans and interaction with foam cells].
August 1980, Kardiologiia,
A W Popow, and A S Kusnezow, and A G Winogradow
Lipoproteins in human atherosclerotic vessels. I. Biochemical properties of arterial low density lipoproteins, very low density lipoproteins, and high density lipoproteins.
April 1979, Experimental and molecular pathology,
A W Popow, and A S Kusnezow, and A G Winogradow
Uptake and degradation of low density lipoproteins in atherosclerotic rabbit aorta: role of local LDL modification.
January 1991, Journal of lipid research,
A W Popow, and A S Kusnezow, and A G Winogradow
Plasma distribution of cyclosporine within lipoproteins and "in vitro" transfer between very-low-density lipoproteins, low-density lipoproteins, and high-density lipoproteins.
July 1991, Therapeutic drug monitoring,
A W Popow, and A S Kusnezow, and A G Winogradow
Hydrazine compounds inhibit glycation of low-density lipoproteins and prevent the in vitro formation of model foam cells from glycolaldehyde-modified low-density lipoproteins.
April 2006, Diabetologia,
A W Popow, and A S Kusnezow, and A G Winogradow
[Influence of serum low-density lipoproteins on psoriatic epidermal lipogenesis (author's transl)].
June 1978, Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology,
A W Popow, and A S Kusnezow, and A G Winogradow
[Inhibiting effect of low density lipoproteins (LDL) on neutrophil function (author's transl)].
January 1979, Annali Sclavo; rivista di microbiologia e di immunologia,
Copied contents to your clipboard!